| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 05/23/2006 | US7049307 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 05/23/2006 | US7048876 Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm. |
| 05/23/2006 | CA2232141C Substituted tetracyclic tetrahydrofuran derivatives |
| 05/23/2006 | CA2189140C New antagonist compounds |
| 05/18/2006 | WO2006051851A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition |
| 05/18/2006 | WO2006051374A2 Arylpiperazines useful as adrenergic receptor antagonists |
| 05/18/2006 | WO2006050965A1 Pyrimidine compounds as histamine modulators |
| 05/18/2006 | WO2006050598A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
| 05/18/2006 | WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 05/18/2006 | US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile |
| 05/18/2006 | US20060106061 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/18/2006 | US20060106050 Thrombin receptor antagonists |
| 05/18/2006 | US20060106048 Furoisoquinoline derivative and use thereof |
| 05/18/2006 | US20060106046 2-(3,4-difluorophenyl)-N-methyl-2-(1H-1,2,3-triazol-1-yl)-N-[3-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1-yl)propyl]acetamide, used for preventing or treating cardiovascular, nervous, metabolic, reproductive, respiratory and/or digestive system disorders |
| 05/18/2006 | US20060106045 Spiroindolinepiperidine derivatives |
| 05/18/2006 | US20060106007 N-((hetero)arylalkyl)pyrimidonecarboxamides in which the ring is fused to a C4-7(hetero)cycloalkyl ring, which in turn has a spiro ring attached: e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-8'-methyl-4'-oxo-spiro[cyclopentane-1,9'(6'H)-[4H]pyrazino[1,2-a]pyrimidine]-2'-carboxamide |
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/18/2006 | US20060104998 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/18/2006 | CA2586316A1 Pyrimidine compounds as histamine modulators |
| 05/18/2006 | CA2585165A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
| 05/17/2006 | EP1657241A1 Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors |
| 05/17/2006 | EP1657239A2 Chromene compound |
| 05/17/2006 | EP1656380A2 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 05/17/2006 | EP1558252A4 Substituted furo 2,3-b| pyridine derivatives |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | CN1774635A Anti-epileptogenic agents |
| 05/17/2006 | CN1774440A Benzoxepino-11-piperidylidene compounds and process for production thereof |
| 05/17/2006 | CN1774437A 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands |
| 05/16/2006 | US7045530 alzheimer's disease; schizophrenia |
| 05/11/2006 | WO2006050435A1 Heterocyclical chromophore architectures |
| 05/11/2006 | WO2006049891A1 Trisubstituted thiophenes as progesterone receptor modulators |
| 05/11/2006 | WO2006048146A1 Quinoline as allosteric enhancers of the gaba-b receptors |
| 05/11/2006 | WO2006013546A3 Process for the preparation of pure galantamine |
| 05/11/2006 | WO2005103039A8 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists |
| 05/11/2006 | WO2005102275B1 Galantamine salts, method of producing it and nasal composition thereof |
| 05/11/2006 | WO2005058893A8 Tricyclic benzimidazoles |
| 05/11/2006 | WO2005058325A8 Tricyclic imidazopyridines for use as gastric secretion inhibitors |
| 05/11/2006 | WO2003091253A8 Nitrosated imidazopyridines |
| 05/11/2006 | US20060100444 2,4,7,9-tetranitro-10H-benzo[4,5]furo[3,2-b]indole (TNBFI) |
| 05/11/2006 | US20060100427 Alzheimer's disease and other diseases relating to amyloid deposits; neurodegenerative diseases |
| 05/11/2006 | US20060100262 Tetracyclic indole derivatives as antiviral agents |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100199 Novel condensed imidazole derivatives |
| 05/11/2006 | US20060100197 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation |
| 05/11/2006 | CA2588278A1 Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 05/11/2006 | CA2586066A1 Quinoline as allosteric enhancers of the gaba-b receptors |
| 05/11/2006 | CA2585337A1 Trisubstituted thiophenes as progesterone receptor modulators |
| 05/11/2006 | CA2584869A1 Heterocyclical chromophore architectures |
| 05/11/2006 | CA2584792A1 Heterocyclical chromophore architectures |
| 05/10/2006 | EP1655303A2 Hydroxylamine esters as polimerization initiators |
| 05/10/2006 | EP1655294A2 Chromene compound |
| 05/10/2006 | EP1655293A2 Chromene compound |
| 05/10/2006 | EP1654326A1 Triangulenium fluorescent dyes and polymers comprising such dyes |
| 05/10/2006 | EP1654257A1 Aminopyrones and their use as atm inhibitors |
| 05/10/2006 | EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 05/10/2006 | EP1653965A1 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 05/10/2006 | EP1282630B1 Process for Reducing the Molecular Weight of Polypropylene Using Hydroxylamine Esters |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | CN1769287A Method for producing pyridine derivatives |
| 05/10/2006 | CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1768745A Agents for improving excretory potency of urinary bladder |
| 05/10/2006 | CN1255403C Beta-carboline derivatives useful as inhibitors of phosphodiesterase |
| 05/09/2006 | US7041763 Photochromic polymers and methods of synthesizing same |
| 05/09/2006 | US7041695 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 05/09/2006 | US7041689 Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase |
| 05/09/2006 | US7041674 nortropane or nortropene derivatives; antagonists of the M3 receptor for treating asthma, COPD, vagally induced sinus bradycardia, arrhythmia, gastrointestinal and urinary tract spasms, and menstrual pain |
| 05/09/2006 | US7041672 Substituted aryl 1, 4-pyrazine derivatives |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041664 e.g., (S)-N-(1-phenylpropyl)-2-(pyrrolidin-1-yl)-quinoline-4-carboxamide in a container with instructions for treating anxiety, depression, schizophrenia, obesity, chronic pulmonary obstructive disorder, or pain |
| 05/09/2006 | US7041354 Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer |
| 05/04/2006 | WO2006046778A1 3-carbamoyl-2-pyridone derivative |
| 05/04/2006 | WO2006046096A2 A polymorphic form of narwedine and its use in the synthesis of galantamine |
| 05/04/2006 | WO2006045204A1 Aryl sulfonic pyridoxines as antiplatelet agents |
| 05/04/2006 | WO2006045203A1 Substituted pyridoxines as anti-platelet agents |
| 05/04/2006 | WO2006005726A3 Heterocyclic compounds |
| 05/04/2006 | WO2004099214A8 Quinoline 3-amino chroman derivatives |
| 05/04/2006 | US20060094767 Antitubercular agent; antibiotic against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria; e.g. (R)-2-methyl-6-nitro-2-(4-(4-(4-trifluoromethoxyphenoxy)piperidin-1-yl)phenoxymethyl)-2,3-dihydroimidazo(2,1-b)oxazole |
| 05/04/2006 | US20060094749 Substituted pyridoxines as anti-platelet agents |
| 05/04/2006 | US20060094748 Aryl sulfonic pyridoxines as antiplatelet agents |
| 05/04/2006 | US20060094746 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-hydroxythieno[2,3-c]isoquin-5(4H)-one, used for treating tumor diseases, leukaemia, sarcoma, tissue damage due to ischemia and reperfusion, inflammatory disease, retinal ischemia or brain trauma |
| 05/04/2006 | US20060094740 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 05/04/2006 | US20060094724 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | CA2585177A1 Aryl sulfonic pyridoxines as antiplatelet agents |
| 05/04/2006 | CA2585174A1 Substituted pyridoxines as anti-platelet agents |
| 05/03/2006 | EP1652926A2 Heterologous production of polyketides |
| 05/03/2006 | EP1652842A1 Indazole derivatives |
| 05/03/2006 | EP1651592A2 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 05/03/2006 | EP1651162A2 Improved cytotoxic agents comprising new maytansinoids |
| 05/03/2006 | EP1562954B1 Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease |
| 05/03/2006 | EP1543011B1 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
| 05/03/2006 | CN1768063A Process for the stereoselective synthesis of lactones |
| 05/03/2006 | CN1768051A Substituted pyrazoles |
| 05/03/2006 | CN1768041A Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |